LCGC Asia Pacific
Wyatt Technology Note
Poly(lactic-co-glycolic acid) (PLGA) is a copolymer based on glycolic acid and lactic acid. The two monomer units are linked together by ester linkages and form linear polyester chains. The obtained product is biodegradable and biocompatible, and it is approved by the Food and Drug Administration (FDA) for production of various therapeutic devices as well as for drug delivery applications. The properties of PLGA can be tuned by the ratio of the two monomers and by its molar mass distribution.
The characterization of PLGA by means of conventional size exclusion chromatography (SEC) is problematic because of the lack of suitable calibration standards. In addition, the linear polyester structure can be modified by the addition of small amounts of polyfunctional monomer to obtain branched chains of differing degrees of branching. The degree of branching becomes an additional parameter that can be used to adjust PLGA properties — all of which renders conventional column calibration an inadequate analytical technique.
In this application note, two commercially available samples were analysed by SEC coupled to a multi-angle light scattering (MALS) detector (HELEOS), a refractive index detector (Optilab rEX) and a viscosity (VIS) detector (ViscoStar). The ViscoStar was used in order to discover additional information about the molecular structure of the analysed polymers. In addition to molar mass distributions, the SEC–MALS-VIS system yields the relationship between intrinsic viscosity and molar mass (Mark-Houwink plot) that can provide deep insight into the molecular structure of the polymers being analysed.
Figure 1: Differential molar mass distribution curves of two PLGA samples.
In Figure 1, the molar mass distributions are given as differential distribution plots. As seen from the plots, the two samples span markedly different molar mass ranges. The Mark-Houwink plots of the two samples are shown in Figure 2 together with the plot of linear polystyrene that is shown simply for the sake of comparison. The slope of the Mark-Houwink plot of the linear polystyrene is 0.71, a typical value for linear random coils in thermodynamically good solvents. The slope of the red sample roughly corresponds to a linear structure as well. However, there is a slight indication of deviation from linearity at the region of high molar masses that may indicate the presence of branched molecules. The Mark-Houwink plot of the blue sample is curved. Curvature of the Mark-Houwink plot generally reveals branching. In addition, the slope of the higher molar mass portion of the Mark-Houwink plot of 0.48 suggests significant branching.
Figure 2: Mark-Houwink plots of two samples of PLGA (red and blue) and linear polystyrene (magenta). The lines are linear extrapolations of the data.
SEC-MALS-VIS is an excellent method for the characterization of PLGA polyesters as it has the ability to determine not only the molar mass distribution, but also to reveal subtle differences in PLGAs molecular structure.
Wyatt Technology Corporation
6300 Hollister Avenue, Santa Barbara, California 93117, USA
tel. (805) 681 9009 fax (805) 681 0123
Website: www.wyatt.com
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.